Improved recovery of active recombinant laccase from maize seed

Lignolytic enzymes such as laccase have been difficult to over-express in an active form. This paper describes the expression, characterization, and application of a fungal laccase in maize seed. The transgenic seed contains immobilized and extractable laccase. Fifty ppm dry weight of aqueously extractable laccase was obtained, and the remaining solids contained a significant amount of immobilized laccase that was active. Although a portion of the extractable laccase was produced as inactive apoenzyme, laccase activity was recovered by treatment with copper and chloride. In addition to allowing the apoenzyme to regain activity, treatment with copper also provided a partial purification step by precipitating other endogenous corn proteins while leaving >90% of the laccase in solution. The data also demonstrate the application of maize-produced laccase as a polymerization agent. The apparent concentration of laccase in ground, defatted corn germ is approximately 0.20% of dry weight.

Effects of cotinine on information processing in nonsmokers

Cotinine, the major proximate metabolite of nicotine, is present in smokers in higher concentrations and for a longer time than nicotine, yet its effects on information processing have not previously been reported. We studied the cognitive effects of cotinine in non-smokers. Sixteen subjects were tested on three doses of cotinine (0.5, 1.0, and 1.5 mg cotinine base/kg), and placebo, on a choice reaction time (RT) task and on a verbal recall task with short and long lists. Cotinine significantly impaired recall on the long list and displayed non-significant but generally consistent dose-related slowing of RT and N100 latency. The acute effects of cotinine were small, and probably do not account for the cognitive deficits observed in tobacco withdrawal, although the cognitive effects of chronic cotinine administration need to be investigated.

The effect of D-amphetamine, clonidine, and yohimbine on human information processing

Twelve subjects were tested with D-amphetamine, yohimbine, clonidine, and a placebo on a task with two levels of stimulus and two levels of response complexity. The purpose of this study was to test the hypothesis that noradrenergic drugs affect early stimulus processes. D-amphetamine speeded reaction time (RT), clonidine slowed it, and yohimbine had no effect. D-amphetamine and yohimbine decreased N1 latency and clonidine increased it. D-amphetamine and yohimbine decreased P3 latency and clonidine increased it but, in each case, only when latency estimates were based on single trials, not on averages. D-amphetamine's effect on RT, not P3, as measured by the average, is consistent with previous results. Single trial measures appear more sensitive. Speeding of N1 and single-trial P3 data indicate that noradrenergic drugs affect processing of early (visual) information. D-amphetamine's speeding of single-trial P3 estimates was attributed to its noradrenergic actions. Yohimbine's speeding of P3 without changing RT is consistent with neural net (parallel) simulations but not with a serial model. These findings support the assumption that different neurotransmitters modulate specific cognitive processes.

A low dose of subcutaneous nicotine improves information processing in non-smokers

Many studies have found that cigarette smoking or nicotine improves mental functioning in abstinent smokers. An unresolved issue is whether this improvement is due primarily to a direct facilitation of performance or to relief of the impairment caused by nicotine withdrawal. We evaluated the performance of 12 non-smokers before and twice (15 and 45 min) after a subcutaneous injection of 0.8 mg nicotine, 0.8 ml saline, and a control no treatment, on a choice reaction time (RT) task. Each treatment was given on a separate day; the control day was given on the first session. The order of nicotine and saline was balanced between subjects, and injections were given double-blind. The RT task manipulated stimulus and response processing. These manipulations consisted of two levels of stimulus complexity and two levels of response complexity, resulting in four task conditions. These manipulations along with latency measures of the event-related potential were used to identify the components of processing that mediated nicotine's effects on performance. During each active drug session blood nicotine levels, cardiovascular, and subjective responses were measured before and after each of the three tests (pre-drug, 15 min and 45 min post-drug). For the information processing measures only the comparisons of the pre- and 15-min post-test showed significant drug effects. Nicotine compared to saline significantly increased the number of responses at the fast end of the RT distribution. However, there were no changes in accuracy. Nicotine also speeded mean RT compared with saline or the control day, but the effects were only significant for the control-nicotine comparison.(ABSTRACT TRUNCATED AT 250 WORDS)

Drugs and human information processing

Human performance on a choice-reaction time task (Eriksen task) has been simulated by a neural network. In simulations, the network captures many features of normal performance. In addition, changing gain in different layers produces changes that simulate different drug-induced changes. Data from a similar choice-reaction time task have been reanalyzed to test some of the predictions derived from changing gain in different layers. Clonidine antagonizes norepinephrine and acetylcholine activities and changes speed-accuracy tradeoff (i.e., increased frequency of errors at any specified reaction time). That is predicted when gain is reduced in lower layers (attention layer and input layer) of the network. By contrast, manipulating dopamine activity (with pimozide and amphetamine) changes reaction time without changing speed-accuracy tradeoff functions. That is predicted when gain is changed in the output layer of the network.

An open trial of low dose buprenorphine in treating methadone withdrawal

Buprenorphine (BPN) is a prescription analgesic with mixed opioid agonist and antagonist properties. This pilot study conducted detailed case studies with 15 methadone dependent patients. The study sought to determine whether repeated low doses (0.15 to 0.3 mg) of sublingual BPN would relieve opioid withdrawal symptoms. Subjects developed mild to moderate withdrawal symptoms within 26 to 31 hours of methadone discontinuation. Once in withdrawal, the subjects received 0.15 mg of BPN sublingually. A second dose of 0.15 mg was administered in an hour, and a 0.30 mg dose in 2 hours, if the subject obtained no relief of withdrawal symptoms. In 6 subjects a low dose of 0.15 to 0.30 mg sublingual BPN resulted in the disappearance of subjective and objective withdrawal symptoms within 10 minutes to 2.5 hours. Four others had brief, partial relief of symptoms. Five subjects failed to experience any relief of withdrawal symptoms after a total of 0.6 mg BPN administered over 3 hours. One nonresponder suffered what appeared to be a severe precipitated withdrawal reaction similar to that which can be produced in addicts by a naloxone challenge. The 4 Caucasian responders required 1 to 2 hours to respond to BPN, whereas the 2 African-American responders required only 10 to 20 minutes. Low (analgesic) doses of BPN were sufficient to treat all methadone withdrawal symptoms in 6 of 15 subjects. There may be ethnic differences in response to BPN. Low dose BPN may play a role in carefully monitored heroin detoxification treatment.

Predictive value of objective esophageal insufflation testing for acquisition of tracheoesophageal speech

This prospective study was undertaken to assess the predictive value of esophageal insufflation on the acquisition of tracheoesophageal (TE) speech. Fourteen total laryngectomy patients were evaluated prior to tracheoesophageal puncture (TEP) using objective esophageal pressure measurements. These patients then were followed prospectively for 6 to 13 months. Speech was assessed at the time of prosthesis fitting, at 1 month, at less than 6 months, and at greater than 6 months post-TEP. No patient underwent pharyngeal myotomy. Pre-TEP esophageal insufflation pressure was associated (P = .065) with successful TE speech at the time of prosthesis fitting, but was not associated with successful TE speech acquisition after 6 months. This study's results suggest that patients with poor pre-TEP esophageal insufflation test results will usually obtain successful TE speech given adequate time and training, even without pharyngeal myotomy.

Cholinergic activity and constraints on information processing

In humans, close relationships are found between cholinergic activity and constraints placed on information processing operations. This is true for all operations where the effects of cholinergic activity have been studied. Studies of vigilance, memory, problem solving, stimulus processing and response processing are cited as illustrations. These studies suggest the hypothesis that cholinergic activity controls constraints in all information processing operations. Alternative hypotheses are proposed and experimental tests are suggested.

Scopolamine effects on visual information processing, attention, and event-related potential map latencies

We measured performance and event-related brain potential (ERP) map latencies in 12 subjects during four visual discrimination tasks to compare the timing of scopolamine effects on information processing and attention. "Topographic component recognition" found ERP map latencies at times of best fit with a component model map. This "common topography" criterion minimized topographic differences among conditions to facilitate latency interpretations. Scopolamine slowed N1 latency in all tasks, and P3 and reaction time in some tasks. The drug delayed responses to easy targets more than to hard targets. It also induced a disproportionate N1 delay for unilateral high spatial frequency gratings. Both effects reflect a scopolamine-induced impairment when processing targets that usually capture attention. Scopolamine also impaired accuracy for unilateral high spatial frequency gratings, and for gratings presented at probable locations, confirming and extending previous findings. Scopolamine-induced P1 and N1 delays showed that visual processing was affected. Several results were inconsistent with a serial stage model. We suggest that scopolamine both delays selected processes and impairs a processing mode based on automatic capture of attention, inducing more serial processing.

Clonidine and scopolamine: differences and similarities in how they change human information processing

1. Humans have been tested on a choice reaction time task designed to disclose interactions between stimulus complexity and drug effect. 2. Tests were carried out using oral scopolamine (1.2 mg) and clonidine (0.2 mg). 3. Reaction times and event related potentials were measured. 4. Both drugs slowed reaction time and the N1 component of the ERP. 5. SCOP slows RTs to easy-to-discriminate stimuli more than RTs to harder stimuli. Its effect on P3 is the same for both types of stimuli. 6. CLON tends to slow P3 latencies to easy stimuli more than P3 latencies to harder stimuli, while the RT slowing is almost identical for both types of stimuli.

Topographic segmentation of waking EEG in medication-free schizophrenic patients

Lehmann has demonstrated that EEG topography can be used to segment EEG map series into a sequence of spatially stationary segments characterized by location of potential maxima and minima. We employed topographic segmentation techniques to study 9 channel EEGs recorded from 11 medication-free schizophrenic patients and 10 normal controls during resting and active task conditions, retesting 8 patients after neuroleptic treatment. To define EEG segments, average reference potential maps corresponding to global field power peaks in theta, alpha, and low beta activity were classified according to locations of extreme minimum and maximum values. Normals and schizophrenics did not differ in the number or types of switches between segments, or the frequency of hemisphere crossing of potential extrema. However, EEGs of normal subjects were characterized by significantly more (P less than 0.003) unused theta segment types (of a theoretically possible 36). Moreover, medication significantly (P less than 0.02) increased the number of unused theta segment types in EEGs of schizophrenics. We interpret these findings as evidence of increased spatial variability of brain electrical activity in schizophrenics and discuss their functional implications.

Nonclosure of pharyngeal muscle after laryngectomy

A prospective study was carried out to evaluate a new technique of pharyngeal repair following laryngectomy. The purpose of this study was to see whether satisfactory healing would occur if the pharyngeal constrictors were not sutured across the closure in the pharynx. If healing proved to be satisfactory the procedure might eliminate the need for primary or secondary myotomy or pharyngeal plexus neurectomy to facilitate tracheoesophageal speech. The results indicate that healing is as good in the group who did not have muscle closure as in those who did.

Beyond drug effects and dependent variables: the use of the Poisson-Erlang model to assess the effects of D-amphetamine on information processing

Several studies have shown that d-amphetamine (DAMP) speeds mean reaction time (RT). However, the use of mean RT may obscure important aspects of the drug response. Therefore we applied the Poisson-Erlang (PE) stochastic model of choice reaction time proposed by Pieters (1985) to the RT distribution. This model proposes that the RT distribution is generated by two states: Processing (P) and Distraction (D). RT represents the sum of the time spent in each of these states. P is the time taken to complete a set of cognitive operations which are required to give a correct response. D represents the time taken by all other activities. RTs were collected using a task (SERS) in which stimulus and response complexity each had two levels, easy and hard. Subjects were tested pre- and postdrug. Drug conditions were: placebo, 10 mg d-amphetamine (DAMP), 4 mg of the dopamine agonist, pimozide, and a combination of DAMP and pimozide (COMBO). Parameters of the model were derived using methods described by Pieters. Four measures were analyzed: Processing Time (PT); Mean Time per distraction (XTD); Distraction Rate (DR); and Total Distraction Time per trial (TDT). Mean RT is also presented. Analyses of the effects of task conditions on the parameters of the model were made using the predrug sessions. Mean RT was increased by both stimulus and response complexities as was PT. TDT was increased by the task conditions. The PE measures did not change over days. DAMP speeded mean RT. However, this effect did not interact with the task factors. DAMP speeded processing and reduced distraction. Processing was speeded only in the hard response condition, distraction time was reduced only in the easy response condition. The results indicate that the PE model can be successfully applied to fast RT tasks. More importantly, the parameters of the model revealed important pharmacological effects that were not apparent in mean RT. DAMP speeds cognitive operations related to motor preparation and reduces the effects of distraction. Consistent with past studies there are no indications that DAMP interacted with stimulus processing. The distraction effect appears to be mediated by an increase in the rate of distraction and a decrease in the average time of these distractions.

Scopolamine and physostigmine do not alter visual detection of change: relationships to a model of lateral geniculate operations

The effects of physostigmine and scopolamine were tested on 5 male subjects using a task based on a model of cross-inhibition among lateral geniculate neurons. The task consisted of detecting and locating a change (appearance or disappearance) of one point of light in an array of points. Earlier research suggested that the task was sensitive to drugs and pathology. In the present study, neither drug showed significant effects on any of three task variables used, although differences between subjects were significant. These findings show that the task is sensitive to individual differences but insensitive to changes in cholinergic activity produced by physostigmine and scopolamine, even though such changes should affect neuronal functioning at the lateral geniculate.

The variety of relations between spatial frequency and reaction time

While stimuli of lower spatial frequency often result in faster responses, this is not invariably the case. Some individuals respond faster to high frequency stimuli on tasks for which most others respond faster to low frequency stimuli. Past experience can also determine the degree to which a low frequency stimulus will mask a high frequency stimulus. These observations suggest that the effects of spatial frequency on visual information processing are under the control of higher level cognitive operations.

The effects of clonidine and yohimbine on human information processing

The effects of clonidine and yohimbine on human information processing were tested in six normal volunteers ages 18-30 years. Subjects were tested in a pre-post design with sessions conducted at weekly intervals. Three drug conditions were: Placebo (lactose), 0.2 mg clonidine, and 30 mg yohimbine. Two choice reaction time (RT) tasks were used. One was a stimulus evaluation-response selection task (SERS) that has been shown to be sensitive to d-amphetamine, methylphenidate and scopolamine. The other task was to assess stimulus pre-processing and used spatial frequency as a discriminative stimulus. The principle finding was that clonidine slowed RT; this effect was significant for both tasks. In contrast, yohimbine tended to speed RT, but the effects were significant only for the spatial frequency task on some analyses while not for others. RTs to high spatial frequency stimuli were speeded more than for low spatial frequency. The effects of these two NE drugs were compared with findings with d-amphetamine and scopolamine and interpreted within the framework of a serial information processing model proposed by Callaway (1983). Specifically, it is suggested that yohimbine and clonidine affect an early pre-processing stage.

The effects of stimulant drugs on information processing in elderly adults

The effects of stimulant drug on information processing in elderly adults was studied. In Experiment 1, the effect of methylphenidate (MP) was examined in 8 young and 8 elderly women using a task (SERS) in which stimulus and response complexities were varied. MP speeded processing in the young but not in the elderly women. A second experiment was then conducted to isolate the age-stimulant effects. In Experiment 2, the effects of MP and 10 mg of d-amphetamine (DAMP) were studied in 12 young and 12 elderly men on different types of information processing. Stimulants changed performance on a continuous performance task in both groups. Both stimulants speeded processing on SERS in young, but not in elderly men. MP, however, speeded processing in both groups on a response processing task. The findings suggest that stimulants act on response processing and there appear to be several such processes. Some of these stages decline with age whereas others do not.

Effects of oral scopolamine on human stimulus evaluation

In a previous study of the effect of age on information processing, both age and stimulus complexity slowed reaction time (RT) and the latency of the P300 component of the brain event-related potential (ERP). The aim of the present study was to compare the effects of scopolamine (an anticholinergic) with the previously noted effects of age. The choice of scopolamine was prompted by current hypotheses concerning decline in cholinergic function with age. Twelve adult women were studied on a battery of tasks before and after scopolamine in oral doses of 0.0 (placebo), 0.6 and 1.2 mg. Reaction times (RT) and event-related potentials (ERP) were measured. The principal task was one that combined two levels of stimulus complexity and two levels of response difficulty to provide four subtasks. Scopolamine slowed RT and P300 as had age, but scopolamine slowed responses to simple stimuli more than responses to complex stimuli. Scopolamine effects on other tasks in the battery were small but consistent with an action of scopolamine on an early stimulus preprocessing stage that is independent of a stimulus evaluation stage that is also affected by age.

The effect of methylphenidate on information processing

Models of information processing currently popular in cognitive psychology divide the reaction process into a series of discrete separable stages. The distinction between one stage and another is verified by the additive factors method (AFM) as defined by Sternberg (1969). Task factors that do not interact with each other are inferred to affect different stages. The distinction between stimulus evaluation stages and response selection stages has been supported by brain event related potential (ERP) studies. The latency of the P300 component of the ERP is sensitive to changes in stimulus complexity but not to to changes in response complexity. The focus of this research is to determine the effects of stimulant drugs on stages of information processing using both reaction time (RT) and P300 latency within an AFM framework. Four doses of methylphenidate (MP) were used in a within-subjects design to examine the effects of MP on stimulus and response processing. We found that MP speeds RT, and that this effect does not interact with the effect of stimulus complexity on RT. MP dose interacts with response complexity, the dose for optimal speeding varying with the level of complexity. The latency of P300 is increased by stimulus complexity, and not by response complexity, nor is it affected by MP. These results show that the stimulant drug acts on processes involved in response selection, rather than in stimulus evaluation. Individual differences in drug response are dose dependent, but also point to an effect on response processing.

Learned histamine release

Most of the effort directed at understanding the problems of allergy has focused on the interacting components of the immune system. The possibility that histamine may be released as a learned response has now been tested. In a classical conditioning procedure in which an immunologic challenge was paired with the presentation of an odor, guinea pigs showed a plasma histamine increase when presented with the odor alone. This suggests that the immune response can be enhanced through activity of the central nervous system.

ERPs and Psychopathology. I. Behavioral process issues

The clinical study of ERPs has an inherent defect--a self-selection of clinical populations that hampers equating of clinically defined groups on factors extraneous to the independent variables. Such ex post facto studies increase the likelihood of confounding variables in the interpretation of findings. Hence, the development of lawful relationships between clinical variables and ERPs is impeded and the fulfillment of description, explanation, prediction, and control in brain science is thwarted. Proper methodologies and theory development can increase the likelihood of establishing these lawful relationships. One methodology of potential value in the clinical application of ERPs, particularly in studies of aging, is that of divided attention. Two promising theoretical developments in the understanding of brain functioning and aging are the distraction-arousal hypothesis and the controlled-automatic attention model. The evaluation of ERPs in the study of brain-behavior relations in clinical populations might be facilitated by the differentiation of concurrent, predictive, content, and construct validities.

Effects of two doses of methylphenidate on verbal information processing in hyperactive children

Nine hyperactive children participated in three sessions. During each they were given one of three drugs (placebo, 10 mg, or 21 mg of methylphenidate) in a double-blind crossover study. Following drug administration they were tested on three cognitive tasks. For one task, structural, acoustic, or semantic degrees of encoding of verbal information were induced. Memory for the verbal information was then tested. The 10-mg dose resulted in overall improvement of word recognition and recall. The 21-mg dose did not result in improvement. Amount of improvement was not related to degree of encoding of words. Two other tasks, learning a list of words and visual search of letters from a briefly presented display, were not affected by either the 10- or 21-mg dose. The results indicate that verbal learning can be facilitated by a low dose of methylphenidate but that the dose range may be narrow. Also, certain individuals did not respond favorably to either dose. In discussing the results, the possibility is presented that methylphenidate-induced facilitation may be restricted to certain types of learning or certain methods of assessing retrieval of information.

Hyperactive children's event-related potentials fail to support underarousal and maturational-lag theories

Hyperactivity in children has been attributed to underarousal, maturational lag, and both. Using event-related potentials (ERPs) and EEG spectra, we compared hyperactive children with age-matched normal controls. Neither underarousal nor maturational lag explained our findings, and we concluded that these explanations are now too simple to be useful. We found a number of differences in EEGs and ERPs between hyperactive subjects and controls. The best single measure was EEG power from 14 to 25 Hz, which was consistent with previous reports. Hyperactive children had lower beta power than normal controls.

Visual evoked potential changes induced by methylphenidate in hyperactive children: dose/response effects

Visual event related potentials (ERP) were recorded from 21 hyperactive children aged 7-13 years under two attention conditions at 4 levels of methylphenidate dose (placebo, low, medium and high). ERP measures were very sensitive to age (under or over 10 years) and attention condition, but less sensitive to drug dose. There appeared to be two classes of drug dose effect on ERP amplitude, those that changed monotonically with dose and those from which dose interacted with attention non-monotonically. Drug effect on ERP amplitude may also depend on age so that opposite effects may occur in young and old children. No latency measures showed a dose effect. It appears that methylphenidate can speed reaction times without shortening ERP latency. This suggests the drug acts more on response-related processes than on stimulus evaluation.

A comparison of methods for measuring event-related potentials

Visual event-related potentials (ERPs) were recorded from 21 hyperactive children under 2 attention conditions and 4 doses of stimulant drug (methylphenidate). This data base was used to evaluate several methods of EP component measurement. These methods were (1) conventional visual peak and trough selection; (2) automatic feature extraction based on peaks; (3) automatic features extraction based on segments; (4) gross amplitude measures; (5) principal components analysis on normalized data and latency-adjusted data. No one method emerged as the best overall. Rather it is the case that different methods are best suited to different purposes, and criteria for choosing methods are outlined.

The effect of attentional effort on visual evoked potential N1 latency

The latency of the visual evoked potential N1 component evoked by nontarget stimuli increases with an increased attention to nontarget stimuli. The latency increase seems related to a general effort at processing, rather than any early filtering. This phenomenon is illustrated in one study of hyperactive children and another of normal young adults. The literature of this phenomenon is reviewed, and various explanations are considered. It does not appear to be a result of a slow negative wave, but rather a genuine effect of one aspect of attention on N1.

An information processing model for schizophrenia

A disorder of information processing must be present for a person to receive the diagnosis of schizophrenia, and is present when schizophrenic symptoms occur along with other diseases. We created a model for this disorder that resolves some paradoxic findings and suggests directions for future study. Basically, schizophrenics have a deficiency in information processing that can be characterized as conscious, serial, and limited in channel capacity. In contrast, those processes that seem automatic, unconscious, parallel, and almost unlimited in capacity seem to be normal or supernormal.

Clinical and biological effects of high doses of vitamin B6 and magnesium on autistic children

In 1973 Rimland reported that some autistic children responded favorably to high doses of vitamin B6. Since this finding, different studies were performed to identify apparently B6 responsive subjects and to critically evaluate clinical and biological B6 responsiveness. Magnesium was included because large doses of B6 might increase irritability. 44 patients (mean age 9.3 years) were examined. All selected children had marked autistic symptoms. The children received a complete diagnostic work-up, including psychiatric, psychological, neurological and medical evaluation. Clinical data were scored using an estimate of global clinical state and numerical rating on a 18 item scale (Behavior Summarized Evaluation). In a first open trial 15 out of 44 children exhibited moderate clinical improvement with worsening on termination of the trial. Thirteen responders and 8 non responders were re-tested in a 2-week crossover, double-blind trial and the responses to the open trial were confirmed. Biochemical data analysis revealed that a significant decrease in urinary homovanillic acid (HVA) levels was observed during B6-Mg administration. During B6-Mg treatment, middle latency evoked potentials exhibited a significant increase of amplitude.

Effects of vitamin B6 on averaged evoked potentials in infantile autism

In autistic children, averaged evoked potentials have been reported to have lower amplitudes and shorter latencies than those of normal children. Also, moderate clinical improvement has been observed in some autistic children after treatment with vitamin B6 and magnesium. We have studied biochemical and electrophysiological effects of vitamin B6 and magnesium in 12 autistic children and in 11 normal children. During treatment of the autistic children with B6, an increase of amplitude of middle-latency evoked potentials and a decrease of urinary homovanillic acid were found. The reverse was noted in the normal subjects.

Effects of pyridoxine and magnesium on autistic symptoms--initial observations

In an open trial, a heterogeneous group of 44 children with autistic symptoms were treated with large doses of vitamin B6 and magnesium. Clinical improvement with worsening on termination of the trial was observed in 15 children. Thirteen responders and 8 nonresponders were retested in a 2-week, crossover, double-blind trial, and the responses to the open trial were confirmed.

[Disturbances in dopamine metabolism in autistic children: results of clinical tests and urinary dosages of homovanilic acid (HVA)]

We have studied disturbances in dopamine metabolism by assaying HVA in urines of 44 autistic children. First a clinical study identifies the main clinical symptoms. This allows to differentiate between "pure" autistic children and autistic children with associated signs. Urinary HVA was significantly higher in autistic children and there was a relationship between severity of autism and HVA levels.

Combined effects of alcohol and sleep deprivation in normal young adults

The effect of combining sleep deprivation and moderate alcohol consumption in male college students differed from the effects of each treatment alone. Following either alcohol or sleep deprivation, there was mild performance impairment, decreased alertness and reduced amplitude and increased latency of cortical evoked potential (EP) components. Heart rate increased after alcohol and anxiety increased after sleep deprivation. When alcohol and sleep deprivation were combined, antagonistic effects were found for most measures (reaction time, heart rate, alertness, anxiety, latency of early EP components), but synergistic effects also occurred (performance accuracy, latency of late EP components). These effects were found in a double-blind experiment using 24 subjects. The experimental treatments were alcohol doses of 0, 0.45 and 0.90 ml/kg of 95% ethanol and 0 and 26 h of sleep deprivation.

EEG patterns during 'cognitive' tasks. II. Analysis of controlled tasks

This experiment was designed to distinguish possible EEG correlates of the cognitive components of tasks from EEG patterns associated with stimulus characteristics, limb and eye movements, and performance-related factors such as subjects' ability and effort. Thirty-two right-handed adults each performed 30 trials, lasting 6-15 sec each, of four simplified, controlled tasks: mental rotation of geometric forms, serial addition of a column of signed digits, substitution of letters with subsequent word recognition and visual fixation. The first three tasks could not be differentiated from each other. Each of these tasks could be differentiated from visual fixation by approximately 10% generalized reductions in alpha and beta band intensities, and slight increases in theta band intensities frontally and occipitally. We conclude that the EEG patterns which differentiated the complex tasks described in Part I were due to inter-task differences in stimulus characteristics, efferent activities and/or performance-related factors, rather than to cognitive differences. With these controls, no evidence for lateralization of different types of cognitive activity was found in the EEG.